Spondylosis

Gleamer, leading company in AI medical imaging, today announces that it acquires Pixyl, a pioneer in FDA- and CE-cleared Neuro MRI applications, and Caerus Medical, developer of cutting-edge Lumbar MRI AI solutions. These strategic acquisitions position Gleamer as the only AI provider with an unmatched, proprietary suite of solutions covering all core imaging modalities—X-ray, Mammography, CT, and now, MRI—further solidifying its leadership in the radiology AI market. With its robust portfolio, Gleamer is redefining the future of AI-powered radiology, providing radiologists with best-in-class tools that optimize efficiency, enhance diagnostic accuracy, and accelerate patient care. This latest expansion ensures that Gleamer remains the first choice for institutions seeking comprehensive AI integration across their imaging workflows. “With the addition of Pixyl and Caerus Medical, Gleamer now offers the most extensive proprietary AI-driven imaging portfolio in the industry. This move marks a transformative leap forward, empowering radiologists with cutting-edge MRI applications while strengthening our leadership in medical imaging AI,” said Christian Allouche, CEO & co-founder of Gleamer. “These acquisitions underscore our unwavering commitment to revolutionizing radiology, accelerating the adoption of AI, and delivering superior diagnostic precision.” Pixyl, an award-winning innovator in brain MRI analysis, is recognized for its flagship product Pixyl.Neuro, which has already gained significant traction. The software enables the early detection of neuroinflammatory and neurodegenerative conditions, including Alzheimer’s disease, unlocking life-changing opportunities for early intervention. With new reimbursement pathways emerging in the U.S., Pixyl’s solutions are poised for rapid adoption, reinforcing its role at the forefront of AI-driven radiology innovation. “Joining Gleamer amplifies the impact of our technology, bringing our breakthrough MRI applications to a global audience,” said Senan Doyle, CEO of Pixyl. “Together, we are setting new standards in AI-powered radiology and driving the future of neuroimaging.” Caerus Medical’s AI technology revolutionizes lumbar spine MRI interpretation, offering unparalleled precision in detecting all relevant findings (disc herniation, stenosis, spondylolisthesis etc.). This comprehensive approach enhances workflow efficiency and diagnostic reliability, streamlining the reporting process for radiologists. “The Caerus Medical team is thrilled to become part of Gleamer, the leader in AI-powered radiology,” said David Vittecoq, CEO of Caerus Medical. “This collaboration will fast-track the deployment of our lumbar MRI application and drive groundbreaking advancements in musculoskeletal imaging.” With these acquisitions, Gleamer’s global workforce surpasses 100 employees across seven countries, bolstering its MRI research and development efforts. The integration of Pixyl and Caerus Medical within Gleamer’s AI Factory will accelerate innovation, ensuring the rapid deployment of next-generation imaging solutions that meet the evolving needs of modern radiology.

CARLSBAD, Calif.--( BUSINESS WIRE )--Carlsmed, Inc. (“Carlsmed” or the “Company”) a MedTech company pioneering AI-enabled personalized spine surgery, today announced FDA 510(k) clearance for the aprevo ® Cervical ACDF Interbody System. This milestone underscores Carlsmed’s commitment to advancing patient-specific spine surgery solutions that enhance outcomes and surgical precision. The FDA previously granted Breakthrough Device designation for Carlsmed’s aprevo ® technology for the treatment of patients with cervical spine disease, recognizing aprevo’s potential to address unmet clinical needs and deliver superior patient care. The Company’s current portfolio of aprevo ® interbody fusion devices for the treatment of lumbar spine disease is commercially available in the U.S. “This 510(k) clearance is a major step forward in our mission to make personalized spine surgery the standard of care,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “More than 350,000 cervical fusion surgeries are performed annually in the U.S. The aprevo ® Cervical ACDF Interbody System will set a new benchmark for improving outcomes for these patients.” Designed to match the unique anatomical and procedural needs of each patient, personalized interbody devices have demonstrated significant improvements in patient outcomes compared to traditional fusion methods, as highlighted in recent clinical publications . The aprevo ® devices are designed using Carlsmed’s proprietary technology platform that leverages AI-driven surgical planning software and digital production to create the personalized spine fusion devices that can be delivered in under two weeks. “Personalized interbody devices like aprevo ® provide surgeons with tools designed to address each patient’s unique anatomy,” said Joseph Osorio, MD, PhD, and neurosurgeon at UC San Diego. “Having this technology available for cervical fusions marks a significant advancement in spinal surgery, with the potential to transform procedures by replacing the limitations of one-size-fits-all implants with level-specific customization, offering enhanced surface coverage and precise alignment, both of which are critical for improving patient outcomes.” Carlsmed plans to commercially launch the aprevo ® Cervical ACDF Interbody System in the U.S. in 2025, expanding its innovative product portfolio to further solidify its leadership in the personalized spine surgery market. About Carlsmed Carlsmed is a high-growth medical technology leader and pioneer in the personalized spine surgery market. Carlsmed’s mission is to revolutionize the standard of care in spine surgery by providing cutting-edge solutions tailored to the unique needs of each patient. The Company’s innovative aprevo ® Technology Platform combines proprietary AI-driven software with patient-specific fusion devices to personalize surgical procedures, improve patient outcomes, and reduce complications. For more information, visit carlsmed.com or contact info@carlsmed.com .

RESTON, Va., Sept. 18, 2024 /PRNewswire/ -- Dr. Ehsan Jazini, renowned spine surgeon at VSI (Virginia Spine Institute), has reached a significant milestone, performing his 100th prodisc® cervical disc replacement surgery at HCA Reston Hospital Center. Dr. Jazini is now the fourth surgeon in the United States to achieve this distinction, further establishing his leadership in advanced spine surgery. Continue Reading Dr. Ehsan Jazini celebrates a landmark achievement at VSI (Virginia Spine Institute), receiving the Prodisc Milestone Award for completing 100 successful procedures with the state-of-the-art Cervical Disc Replacement System Spine Surgeon Dr. Ehsan Jazini successfully completes his 100th prodisc surgery, showcasing the modern surgical techniques that make VSI a leader in motion-preserving spine surgery. With this milestone, Dr. Jazini has demonstrated his expertise in providing patients suffering from neck conditions with modern surgical options that alleviate pain and preserve natural neck motion. He has successfully performed over 1,000 cervical artificial disc replacement surgeries, utilizing devices from four leading companies. This advanced procedure provides an effective treatment for conditions such as degenerative disc disease, herniated discs, spondylosis, radiculopathy, and myelopathy, offering patients pain relief while preserving natural neck motion. "Reaching the 100th prodisc surgery milestone is a testament to my commitment to providing the most advanced, motion-preserving solutions in spine care," said Dr. Jazini. "Each procedure is tailored to meet the patient's specific needs, allowing them to regain mobility and live pain-free, active lives. This achievement highlights my dedication to innovation and solidifies my leadership role in modern spine surgery." Dr. Jazini frequently utilizes the prodisc® C SK and prodisc® C Vivo implants in his surgeries, both offer customized solutions designed to match the patient's unique anatomy. The prodisc system features 84 subtypes and size variations, ensuring optimal fit for the specific level of the treated spine. The implant's ball-and-socket mechanism mirrors the technology used in joint replacements, maintaining the physiological range of motion in the cervical spine. For more information on Dr. Jazini's expertise and advanced spine care options at VSI, visit or contact +1 703.709.1114. SOURCE Virginia Spine Institute WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED